Catalyst Wire Dossier Catalyst Wire Dossier

Befizal

unspecified · unspecified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Befizal, covering 2023-09-22 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy [Phase 2, Phase 3]

See pricing